福萨普拉迪布在一项随机控制的多中心蒙面研究中,对患有疑似急性胰腺炎的狗进行了随机控制的多中心蒙面研究
Joerg M Steiner1, Chantal Lainesse2, Yuya Noshiro3
1Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Journal of veterinary internal medicine
|October 9, 2023
概括
发现一种新型治疗方法Fuzapladib在改善急性胰腺炎 (AP) 的狗的临床活性得分方面是安全有效的. 需要进一步的研究来评估其对生存和住院时间的影响.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 目前对狗的急性胰腺炎 (AP) 管理缺乏具体的治疗方法,依赖于支持性护理.
- 富扎普拉迪布是一种新型白细胞功能相关抗原类型-1 (LFA-1) 激活抑制剂.
- 富扎普拉迪布可以减少中性粒细胞驱动的炎症和胰腺炎的进展.
研究的目的:
- 评估被诊断患有急性胰腺炎 (AP) 的狗中富沙普拉迪布的安全性和临床反应.
主要方法:
- 一项随机化,蒙面化,安慰剂控制的多中心研究,涉及61只假定AP的狗.
- 在所有61只狗中评估了安全性;在35只狗中评估了临床疗效 (16只富扎普拉迪布,19只安慰剂).
- 从第0天到第3天,通过修改临床活动指数 (MCAI) 得分的变化来衡量临床改善.
主要成果:
- 在所有接受治疗的狗中,Fuzapladib的耐受性很好,这表明它具有良好的安全性.
- 与安慰剂组 (P=.02) 相比,用fuzapladib治疗的狗在MCAI得分上显示出显著更大的改善.
- 在二次结果测量中没有发现显著差异,包括CAPCSI得分和特定血清生物标志物.
结论:
- 富扎普拉迪布的使用对有AP的狗是安全的.
- 根据两个活性评分,在治疗富扎普拉迪布时观察到有利的临床反应.
- 这项研究并没有调查富扎普拉迪布对生存率或住院时间的影响.
相关概念视频
Acute Pancreatitis I: Introduction
383
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
383
Acute Pancreatitis II: Clinical Manifestations and Management
134
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
134
Chronic Pancreatitis II: Collaborative Care
99
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
99
Chronic Pancreatitis I: Introduction
98
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
98
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
526
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
526
Inflammatory Bowel Disease IV: Pharmacological Management
137
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
137


